
Bartronics India Ltd Enters MoU with Huwel Lifescience Private Limited for Strategic Collaboration and Equity Investment
Bartronics India Ltd (BIL) has entered into a Memorandum of Understanding (MoU) with Huwel Lifesciences Private Limited (Huwel). The purpose of the MoU is to record the mutual intent of the Parties for a strategic collaboration and equity investment. BIL has agreed to invest INR 50,00,00,000 in Huwel, resulting in BIL holding 15% of the fully diluted equity share capital of Huwel. The strategic collaboration includes joint business development, technology enablement, procurement support, and digital outreach by BIL; collaboration for research, product development, launch of new healthcare products, and expansion into domestic and global markets; and establishment of a long-term strategic partnership aimed at assured business flows, innovation, product diversification, and growth in domestic and global healthcare markets.
Key Highlights
- Bartronics India Ltd enters MoU with Huwel Lifesciences Private Limited
- BIL to invest INR 50,00,00,000 in Huwel, holding 15% of the fully diluted equity
- Strategic collaboration for joint business development, technology enablement, and procurement support
- Collaboration for research, product development, and expansion into domestic and global markets
- Long-term strategic partnership for assured business flows, innovation, and growth